Tweetovi

Blokirali ste korisnika/cu @frivadei

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @frivadei

  1. 22. sij

    Looking forward to a great course, not only about running a GWAS but also the exciting downstream analysis thereafter. Hosting and Felix Day.

    Poništi
  2. 26. stu 2019.

    GEMSTONE Meeting Malta inspiring @ Saint Julian'S, Malta

    Poništi
  3. 26. stu 2019.

    Heading to Malta to the first GEMSTONE COST Meeting... putting minds together to translate genomic discoveries to osteoporosis clinical practice

    Poništi
  4. 23. stu 2019.

    Honored to be part of this effort... science without borders! Kudos for the team lead by

    Poništi
  5. 22. stu 2019.

    Is Christmas time! Xmas tree plot of heIght GIANT GWAS by plus awesome lectures on LDS regression & reproductive traits (Felix Day/), MR (Carolina Borges), Cancer (Doug Easton) and Adipocity ()... next edition SNP-course Rotterdam in 2020!

    Poništi
  6. 4. svi 2019.

    Spring break in Scheveningen @ Scheveningen, Zuid-Holland, Netherlands

    Poništi
  7. proslijedio/la je Tweet
    28. pro 2018.

    Thank You to Our 2018 Reviewers! The ® and ® Plus editors are very grateful to the bone, mineral and musculoskeletal experts who volunteered their time to review nearly 1,000 manuscripts in 2018

    Poništi
  8. proslijedio/la je Tweet
    20. pro 2018.

    I’m very saddened to hear of Dr Katz’s passing. He was always supportive of our research and nurtured many careers. He will be deeply missed. Condolences to the staff and his family.

    Poništi
  9. 9. stu 2018.

    Awesome milestone in an awesome carrier kudos!!!

    Poništi
  10. proslijedio/la je Tweet
    10. lis 2018.

    A nice summary of the promises and challenges of polygenic risk scores 👇

    Poništi
  11. 28. ruj 2018.
    Poništi
  12. proslijedio/la je Tweet
    28. ruj 2018.

    Glimcher: The paper that started it all. Massively high bone mass in Schnirri3 KOs

    Poništi
  13. proslijedio/la je Tweet
    23. ruj 2018.
    Poništi
  14. 20. ruj 2018.

    Here is one exam question needing update... among providing 4 different numbers probably the best answer now is: E. Currently Undetermined!

    Poništi
  15. 20. ruj 2018.

    Awesome recognitions from the past <Lodewijk Sandkuijl memoriam> and present <Cisca Wijmenga> for their legacy as great scientists and amazing persons!

    Poništi
  16. proslijedio/la je Tweet

    Doug Altman was a Cochrane leader and pioneer since the beginning in 1993. Everyone within the Cochrane community was sad to learn of his death this year. Watch an interview with Doug where he answers 6 important questions:

    Poništi
  17. 17. ruj 2018.

    GEFOS work scrutinizing the clinical determinants of risk using Mendelian randomization: interventions targeting BMD increase more likely to be successful, no evidence that widespread supplementation works. Mind not the image & see you in Montreal!

    Poništi
  18. 13. ruj 2018.

    Definitively an excellent piece to reflect about scientific contributions and the definition of authorship. The cautivating “every five day” metric holds a tint of malice harming genuine publication processes. Great answers and arguments in the supplement deserving reading.

    Poništi
  19. proslijedio/la je Tweet
    31. kol 2018.

    Each human cell packs 46 chromosomes in its nucleus. For the first time, we resolved their 3D structure in single cells with high spatial resolution. Our Dip-C paper (with and of the X.S.Xie Lab, and ) is now in Science ().

    Prikaži ovu nit
    Poništi
  20. 30. kol 2018.

    Proud of the power of collaborative networks bringing robust evidence to clinical care. See our paper shedding light on fracture risk factors & misconception that widespread supplementation can be effective reducing risk... well is NOT!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·